奥扎格雷联合低分子肝素钙治疗脑血栓临床疗效观察
2015-09-28金梅香
金梅香
奥扎格雷联合低分子肝素钙治疗脑血栓临床疗效观察
金梅香
目的 探究奥扎格雷联合低分子肝素钙治疗脑血栓的临床效果。方法 选取我院2013年2月~2015年2月收治的86例脑血栓患者作为观察对象,按照抽签法随机分为观察组(n=43)和对照组(n=43),对照组患者采用低分子肝素钙来进行治疗,观察组患者在对照组的基础上再联合使用奥扎格雷来进行治疗。观察两组患者的治疗效果。结果 观察组患者的治疗总有效率为95.3%,明显高于对照组的74.4%,组间对比差异明显,具有统计学意义(χ2=7.340 4;P<0.05)。结论 奥扎格雷联合低分子肝素钙治疗脑血栓具有较好的临床效果,患者的治疗有效率高,能够有效缓解患者的病痛困扰。
奥扎格雷;低分子肝素钙;脑血栓
【Abstract】
Objective To explore the clinical effect of ozagrel combined with low molecular weight heparin calcium in the treatment of cerebral thrombosis. Methods From 2013 February 2015, 86 cases of cerebral thrombosis patients selected in our hospital as the observation object, according to the draw method were randomly divided into observation group (n = 43) and control group (n = 43), the control group of patients with low molecular weight heparin calcium, observation group patients in the control group on the basis of combined with Aozhageleilai. Observed the therapeutic effect of the two groups. Results The total effective rate of the treatment group was 95.3%, which was significantly higher than that in the control group 74.4% ,There were statistically significant differences between the two groups(χ2=7.340 4;P < 0.05). Conclusion Ozagrel combined with low molecular weight heparin calcium in the treatment of cerebral thrombosi has positive effect, with high efficiency, can effectively relieve patients pain distress.
【Key words】Ozagrel,Low molecular heparin,Cerebral thrombosis
脑血栓是一种临床上常见的疾病,是由于患者的脑动脉主干或皮质支动脉粥样硬化导致血管增厚、管腔狭窄闭塞和血栓形成,引起脑局部血流减少或供血中断,脑组织缺血缺氧导致软化坏死出现局灶性神经系统症状[1]。患者的临床症状多表现为感觉障碍、轻瘫、排尿障碍、偏身肌张力障碍等情况[2]。临床上常用的治疗方法是给予患者服用低分子肝素钙,但患者的恢复效果并不理想,知晓的有效率不高。对此,有学者提出采用奥扎格雷联合地分析肝素钙来进行治疗,能够有效提高患者的治疗效率。针对这一观点,我院选取了86例患者来进行实验观察,探究奥扎格雷联合低分子肝素钙治疗脑血栓的临床效果,具体报道如下。……
